CRISPR/Cas9 technology generated a CGG to TGA change in exon 4 resulting in an arginine to X substitution at amino acid 294 (p.R294X). This mutation is commonly found in humans with Rett Syndrome. Immunoblotting detected a truncation product at 45 kDa. (J:296009)